Marketing and Privacy Issues: An Analysis of the MMA and Proposed Regulations September 2, 2004 Issue Brief This paper, by Joy Pritts of the Health Policy Institute at Georgetown University, looks at issues related to drug plan marketing activities and privacy under the MMA.Issue Brief (.pdf)
Grievance and Appeals Procedures: An Analysis of the MMA and Proposed Regulations September 1, 2004 Issue Brief This paper, by Sara Rosenbaum, J.D., Director of the Center for Health Services Research and Policy at George Washington University, examines the procedures for resolving beneficiaries' grievances and appeals under the new Medicare drug benefit. It is one in a series commissioned by the Kaiser Family Foundation that analyzes issues…
Selected Findings on Knowledge and Understanding of the New Medicare Rx Drug Program — May/June 2004 Kaiser Health Poll Report Survey June 30, 2004 Poll Finding Topline findings from the May/June 2004 Kaiser Health Poll Report survey, including knowledge and opinions about the new Medicare prescription drug law.Survey Toplines (.pdf)
The New Medicare Drug Benefit: Potential Effects of Pharmacy Management Tools on Access to Medications June 29, 2004 Issue Brief The New Medicare Drug Benefit: Potential Effects of Pharmacy Management Tools on Access to MedicationsThis report describes the pharmacy benefit management tools that will be available to private plans administering the new Medicare drug benefit, including formularies, the definition of categories and classes, and cost sharing requirements. The authors conclude…
Prescription Drug Coverage for Medicare Beneficiaries: A Summary of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 November 30, 2003 Report This document, prepared by Health Policy Alternatives, Inc., provides a detailed summary of the prescription drug provisions of the Medicare legislation (P.L. 108-173) signed by the President on December 8, 2003.Report (.pdf)
Out-of-Pocket Cost-Sharing Obligations for Low-Income Medicare Beneficiaries Under the House and Senate Prescription Drug Bills September 29, 2003 Issue Brief This issue paper provides information on the out-of-pocket expenses for prescription drugs that low-income individuals would face under the Senate versus the House Medicare prescription drug benefit legislation. Issue Paper (.pdf)
Medicare Part D 2011 Data Spotlights September 30, 2011 Report The Kaiser Family Foundation has issued a collection of analyses related to the Medicare Part D stand-alone drug plan options available to seniors for calendar year 2011. These spotlights focuses on key aspects of the drug plan choices available and relevant trends since the Medicare drug benefit took effect in…
Medicare Part D 2010 Data Spotlights August 31, 2010 Issue Brief The Kaiser Family Foundation has issued a collection of analyses related to the Part D Medicare stand-alone drug plan options available to seniors for calendar year 2010. Each of these spotlights focuses on a key aspect of the drug plans that will be available to Medicare beneficiaries in 2010 and…
Study Finds Advertising By Insurers Favors Medicare Advantage Over Stand-Alone Drug Plans August 31, 2008 Issue Brief As the marketing period for 2009 Medicare plans nears, the Kaiser Family Foundation Kaiser Family Foundation issued a report analyzing the content and frequency of television, print and radio advertisement for private Medicare plans that ran nationally or in one of three local media markets (Miami/Fort Lauderdale, Fla.; Phoenix, Ariz.;…
Medicare Part D 2008 Data Spotlight: Formularies January 2, 2008 Issue Brief This Medicare Part D data spotlight examines the formularies (list of covered drugs) of Medicare stand-alone prescription drug plans in 2008, changes since 2006, and differences in how plans cover brand-name and generic drugs. This is one in a series analyzing key aspects of the 2008 Medicare Part D prescription…
